PBM REGULATION,INVESTIGATION,PROSE CUTION,AND COMPLIANCE PHARMA AUDIOCONFERENCE FEBRUARY 10, 2004

Similar documents
POTENTIAL FRAUD ISSUES IN THE OPERATION OF PHARMACY BENEFIT MANAGEMENT ENTITIES

Federal and State Litigation Regarding Pharmacy Benefit Managers

DEVELOPMENTS IN THE PRESCRIPTION DRUG MARKET: OVERSIGHT. Before the Full House Committee on Oversight and Government Reform.

CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training

Compliance and Fraud, Waste, and Abuse Awareness Training. First Tier, Downstream, and Related Entities

Developed by the Centers for Medicare & Medicaid Services Issued: February, 2013

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training. Developed by the Centers for Medicare & Medicaid Services

Contracting with Specialty Pharmacies and Hubs 17 th Annual Pharma and Medical Device Compliance Congress. October 20, 2016

Medicare Parts C & D Fraud, Waste, and Abuse Training

Objectives: Pharmacist Liability

Developed by the Centers for Medicare & Medicaid Services

This course is designed to provide Part B providers with an overview of the Medicare Fraud and Abuse program including:

The People of the State of New York, by their attorney, Eliot Spitzer, Attorney General of

HEATHER I. BATES Managing Director, BRG Health Analytics. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, 2 nd Floor Washington, DC 20036

Medicare Part D: Retiree Drug Subsidy

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All NEW YORK WORKFORCE MEMBERS

PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS*

MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE. Reporting Requirements: Audit Preparedness for PDPs and Manufacturers

PHARMACY BENEFIT MANAGER (PBM)

PREVENTION, DETECTION, AND CORRECTION OF FRAUD, WASTE AND ABUSE

Pharmacy Benefit Managers Overview

GERALD (JERRY) LEWANDOWSKI. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, Second Floor Washington, DC 20036

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All MASSACHUSETTS WORKFORCE MEMBERS

MATTHEW T. SCHELP. St. Louis, MO office:

STATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)

Inside: Critical information about your company s prescription drug benefit.

Analysis of the New Medicare Part D Drug Benefit and Changes to Medicare Part B Reimbursement: New Rules of the Road

Pharmacy Compliance- Credentialing, HIPAA and Fraud, Waste and Abuse (FWA) ACPE# L04-P ACPE# L04-T

Amy Bingham, Compliance Director Reviewed Only Date: 6/05,1/31/2011, 1/24/2012 Supersedes and replaces: "CC-02 - Anti-

Health Care Fraud Challenges to Medicare, Medicaid and Commercial Plans October 5, 2018

LITIGATING AWP. Mitch Lazris/Lyndon Tretter Hogan & Hartson L.L.P. November 15, 2002

Structuring Specialty Pharmacy Distribution Arrangements in a Turbulent Regulatory Environment Mini Summit XVIII

Senate Amendment to Senate Bill No. 539 (BDR ) Title: Yes Preamble: No Joint Sponsorship: No Digest: Yes

STATEMENT OF MICHAEL F. HERTZ DEPUTY ASSISTANT ATTORNEY GENERAL CIVIL DIVISION UNITED STATES DEPARTMENT OF JUSTICE BEFORE THE

REGULATORY ISSUES IMPACTING SUPPLY CHAIN

Pharmacy Benefit Manager Licensure and Solvency Protection Act

Dealing with PBMs: Can I have an aspirin?

Track III-A. Creating Relationships with Prescription Drug Plans and Managed Care Organizations

IEHP Medicare DualChoice Program Pharmacy Program Manual

!"#$% &!'()*+$",-."%%%)$% &!'()*+$ What are PBMs?

DAVID A. BALTO ATTORNEY AT LAW 1325 G STREET, NW SUITE 500 WASHINGTON, DC 20005

COMPLIANCE WITH PATIENT ASSISTANCE PROGRAMS AND CO-PAY CARDS. Judd Katz JD MHA November 2016

Pharmacy Compliance. Oversight - Many Watchful Eyes. Historical Pharmacy Compliance Programs

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training

How the Blueprint Policy Statement to Lower Drug Costs and Reduce Out-of- Pocket Costs May Affect Employers

SUNY DOWNSTATE MEDICAL CENTER POLICY AND PROCEDURE. No:

ANTI-FRAUD PLAN INTRODUCTION

Fraud and Abuse Compliance for the Health IT Industry

1 SB By Senator Marsh. 4 RFD: Banking and Insurance. 5 First Read: 19-MAY-15. Page 0

United HealthCare. New York State Health Insurance Program Payments for Prescription Drugs Dispensed by Kings Pharmacy Under the Empire Plan

1 SB By Senators Beasley, Smitherman, Irons, Bussman and Ross. 4 RFD: Health. 5 First Read: 12-APR-11. Page 0

(B) The ease with which pseudoephedrine can be extracted from a product and whether it forms a salt, emulsion, or other form; and

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO EASTERN DIVISION ) lasetco cv

GOALS OF THIS PRESENTATION HOW WE GOT HERE WHERE WE ARE MANDATORY COMPLIANCE REQUIREMENTS LESSONS FROM MANDATORY COMPLIANCE IN NEW YORK MY PREDICTIONS

Amgen GLOBAL CORPORATE COMPLIANCE POLICY

Moving From PBM to PBA Model

Montefiore Medical Center Compliance Program. Welcome House Staff Orientation

National Policy Library Document

Required CMS Contract Clauses Revised 8/28/14 CMS MCM Guidance Chapter 21

Potential Perils of Using New Media in Marketing and Promotion. Christina M. Markus (202)

The Management of Specialty Drugs: Opportunities and Challenges

U.S. Risk Underwriters Boston ( ) Dallas ( ) Houston( )

MMP (CalMediconnect) Community Health Group. and. First Tier, Downstream & Related Entity

The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer s Perspective

The False Claims Act and Off-Label Promotion: Understanding and Minimizing the Risks for Pharmaceutical Manufacturers

Cardinal McCloskey Community Services. Corporate Compliance. False Claims Act and Whistleblower Provisions

Commitment to Compliance

Medicaid Program; Covered Outpatient Drugs; Proposed Rule (CMS-2345-P) NHIA Summary

Subject: Pharmacy Services & Formulary Management (Page 1 of 5)

AGENCY POLICY. IDENTIFICATION NUMBER: CCD001 DATE APPROVED: Nov 1, 2017 POLICY NAME: False Claims & Whistleblower SUPERSEDES: May 18, 2009

American Bar Association. Technical Session Between the Department of Health and Human Services and the Joint Committee on Employee Benefits

AN ACT. Be it enacted by the General Assembly of the State of Ohio:

This policy applies to all employees, including management, contractors, and agents. For purpose of this policy, a contractor or agent is defined as:

A DISCUSSION WITH THE OIG

Health Care Compliance Association: Medicare Part D Compliance Conference

STAR GAS PARTNERS, L.P.

Code of Conduct/Ethics Policies and Procedures

88 Section 6 Get Information about Prescription Drug Coverage

Texas Finance Code, Chapter 393

Federal Fraud and Abuse Enforcement in the ASC Space

Specialty Pharmacy Trends: Payer and Industry Considerations for Specialty Pharmacies

Corporate Compliance Topic: False Claims Act and Whistleblower Provisions

Anti-Kickback Statute and False Claims Act Enforcement

DEPARTMENT OF HEALTH AND HUMAN SERVICES. Office of Inspector General s Use of Agreements to Protect the Integrity of Federal Health Care Programs

Compliance Program. Health First Health Plans Medicare Parts C & D Training

Prescription Drug Benefit Manual

EFFECTIVE DATE August 17, ISSUED BY: Compliance and Legal Department APPROVED BY: Board of Directors

The Intersection of Specialty Pharmacy and the Law

Industry Consolidation: Role of Compliance in Mergers, Acquisitions, and Divestitures

Your Prescription Drug Benefit Handbook

SOAH DOCKET NO C TDI CASE NO Argus Health Systems, Inc. Administrative Hearings. First Amended Notice of Hearing

The State of New Mexico Group Benefits Plan Plan Year: January December 2018 Prescription Drug Program

CARIBBEAN DEVELOPMENT BANK STRATEGIC FRAMEWORK FOR INTEGRITY, COMPLIANCE AND ACCOUNTABILITY PILLARS I, II AND III WHISTLEBLOWER POLICY

Charging, Coding and Billing Compliance

PECD Acute Drug Formulary

Industry Funding of Continuing Medical Education

What is the HHS OIG?

NewYork-Presbyterian Hospital Sites: All Centers Hospital Policy and Procedure Manual Number: D160 Page 1 of 8

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL INTRODUCED BY WHITE, STREET, BARTOLOTTA, COSTA, FONTANA AND BREWSTER, APRIL 18, 2017 AN ACT

Transcription:

PBM REGULATION,INVESTIGATION,PROSE CUTION,AND COMPLIANCE PHARMA AUDIOCONFERENCE FEBRUARY 10, 2004 James G. Sheehan 615 Chestnut Street, Suite 1250 Philadelphia, PA 19106 Phone: (215) 861-8301 E-mail: Jim.Sheehan@usdoj.gov

DISCLAIMERS OUR OWN OPINIONS - NOT OFFICIAL GOVERNMENT POSITION LIMITED IN WHAT WE CAN SAY ABOUT PENDING LITIGATION GOVERNMENT COMPLAINT AGAINST MEDCO-MEDCO HAS RIGHT TO JURY TRIAL, AND TO PUT GOVERNMENT TO ITS PROOF AT THAT TRIAL YOU SHOULD READ THE MEDCO COMPLAINT (AVAILABLE BY EMAIL)

WHY DOES TRANSPARENCY MATTER? WHEN SOMEONE CREATES A SYSTEM IN WHICH YOU CAN T TELL WHETHER OR NOT YOU RE BEING FOOLED, YOU RE BEING FOOLED. (P.J. O Rourke, How to Stuff a Wild Enron, Atlantic Monthly, April 2002.)

DOES TRANSPARENCY MATTER? WHOSE HEALTH IS IT? WHOSE COST IS IT? SHOULD PROFESSIONALS PROVIDE ADVICE WITHOUT KNOWLEDGE OF COST IMPLICATIONS? DO PLAN FIDUCIARIES HAVE A DUTY TO INVESTIGATE COST IMPLICATIONS BEFORE SELECTING A PBM? GOOD FAITH AND FAIR DEALING / BREACH OF TRUST / FIDUCIARY RELATIONSHIP

Pharmacy Benefit Issues 10-15% increase in prescription drug costs per beneficiary each year Costs driven by: More drugs per patient More expensive new drugs Growth of long-term drug use Aging population(older people use more drugs) PBM role: promoting expensive drugs, capturing spreads

CORE PBM CONCERNS PBMs generally do not get paid for managing the drug benefit, or taking risk PBMs get paid for filling prescriptions PBMs get paid by drug manufacturers for switching prescriptions PBMs get paid for processing prescription claims

CORE PBM CONCERNS Health Plans Have Turned over 15% of their business to PBMs with little incentive for cost or fraud control. PBM contracts are negotiated by plan managers and consultants with limited expertise in fraud and cost control. PBMs limit access to their information, and to data systems and software, which could allow cost and fraud control.

Roles of Pharmacy Benefit Manager 1) ADMINISTRATOR OF RETAIL PHARMACY NETWORK 2) DATA WAREHOUSE/FRAUD DETECTOR 3) MAIL ORDER PHARMACY 4) PLAN DESIGNER/BENEFITS ADMINISTRATOR 5) NEGOTIATOR/AGENT FOR DRUG DISCOUNTS FROM MANUFACTURERS

Administering Retail Pharmacy Network Qualifying pharmacies for network participation Auditing, investigating pharmacies Negotiating price/service w/pharmacies Excluding pharmacies

Qualifying Pharmacies State licenses pharmacy, pharmacists, technicians DEA licenses - controlled substances State inspections, DEA inspections, violation notices, prosecutions Criminal / civil prosecutions

Auditing,Investigating Pharmacies What are incentives? PBM is paid for each prescription processed, even fraudulent ones PBM is not paid for investigative services, law enforcement referrals Sample coupons / account charges

PBM which finds fraud may be liable to clients for losses resulting from fraud How do you know your patient got this prescription? unlicensed / unauthorized physicians Shorting prescriptions No pickup-return to stock Controlled substances records issues

Excluding Pharmacies Follow-up - law enforcement and insurance investigation Attempts - Who is probing the system for weaknesses? Bad physician DEA numbers, bad member numbers Linkages to bad physicians,member fraud

Data Warehouse/Fraud Detector Largest non-governmental computer system Single biggest point of interaction between health plans and consumers-more transactions, more information No connection between med / surg information and drug information - is this a treating physician? Is this drug for a diagnosis for which patient is being treated?

MAIL ORDER PHARMACY PBMs operate mail order pharmacies PBMs operate mail order call centers, where patients and physicians call pharmacists for information PBMs provide pharmacy counseling These pharmacy activities are governed by OBRA 90 requirements and State Pharmacy Licensing Laws

Mail Order Pharmacy Duties Licensed Pharmacist must review prescription Licensed Pharmacist must call prescribing physician if: - Prescription is unclear as to drug,strength, dosage, or instructions ( Doctor Call ) - Prescription history raises concerns about drug interaction, patient allergies, or other patient risks (Drug Utilization Review - DUR ) - Plan or PBM wants to switch patient to different chemical compound

Mail Order Pharmacy Duties Licensed Pharmacist must review prescription container and contents prior to dispensing (back end checking) to determine: Right drug Right strength Right patient Right patient instructions Right Dosage

Mail Order Pharmacy Duties Must not delegate pharmacist duties to non-pharmacists, except as specifically authorized by state law. Pharmacy techs Supervision requirements

Mail Order Pharmacy Duties Must dispense the prescription written by the physician unless: Physician authorizes change Drug is not in stock Pharmacist advises patient and physician that prescription will not be filled

Mail Order Pharmacy Duties Must provide number of pills ordered and paid for (no shorting) Must ship product ordered (or, in some states, generic equivalent) Must not put returned goods back in stock Must provide accurate response to WHIZMO (Where s my order) calls

Why would Mail Order Pharmacy Cheat? Pharmacist staffing shortages Pharmacist services are expensive - need to reduce pharmacist labor Pharmacy contracts require prompt turnaround time-calls delay turnaround

How to Detect Mail Order Pharmacy Fraud Very Difficult-Data is in hands of perpetrator - intentionally difficult to compile and analyze Employee complaints - to whom? Customer complaints - but whom do they complain to? What records of complaints? Pharmacy board, PBM, Employer, Health Plan, Congress, State Legislatures 88% of plan beneficiaries do not know who their PBM is

EMPLOYER OF LICENSED PHARMACISTS AND PHARMACY TECHNICIANS As an employer of licensed professionals, a PBM has a legal duty not to interfere with the performance of a pharmacist s professional duties.

PBM AS NEGOTIATOR/AGENT PBM negotiates price discounts, disease management programs, and rebates in return for formulary position with drug manufacturers on behalf of plans PBM has duty to act on behalf of principal 18 U.S.C. 1346 PBM has duty not to solicit or accept improper payments from manufacturers to affect their judgment or advice to clients

PBM AS NEGOTIATOR/ AGENT Most PBMs take payments from pharmaceutical companies to influence the ordering of prescription drugs by doctors, and the purchase of prescription drugs by patients. Potential problems with these payments:

If they don t disclose to physicians their financial interest in advocating a switch from one drug to another for a patient. calling on behalf of your health plan preferred formulary to keep benefit affordable

If they advocate switches which result in actual physical or emotional harm or risk of harm to patients.

If they advocate switches which result in higher costs to patient or the plan, and don t disclose this fact to both the patient and the plan.

If they advocate switches which result in other additional costs to patients and plans - physician visits, lab costs, in-patient hospitalization, and they don t disclose these facts to both the patient and the plan.

If they make secret deals with manufacturers to not disfavor that company s drugs, involving payments or stock arrangements, with no disclosure to patients, physicians, or payors.

PENDING CASES AGAINST PBMs USA V. MEDCO HEALTH AMENDED COMPLAINT FILED DECEMBER 9,2004

Medco Complaint Allegations False claims from pharmacy operation Improper prescription cancellations/prescription destruction Failure to perform legal pharmacy responsibilities-conflict with production pressures doctor calls,dur, Managed Care

MEDCO COMPLAINT ALLEGATIONS Lack of effective compliance program as evidence of reckless disregard Kickbacks to health plans to obtain PBM contracts False statements, mail fraud on all beneficiaries (federal and private) as basis for mail fraud injunction

FEDERAL ENFORCEMENT ISSUES 1. False Claims Act-civil and criminal (31 U.S.C. Sec. 3729-3733, 18 U.S.C. 267?) 2. Public Contracts Anti-Kickback Act-civil and criminal (41 U.S.C. 52) 3. False Records or Statements-criminal (18 U.S.C. 1001)

4. Health Care Fraud-18 U.S.C. 1035 5. Health Fraud Injunction 18 U.S.C. 1345 6. DEA violations/controlled substances 7. Restitution/Disgorgement

State Enforcement Issues 1. Unfair Trade Practices 2. Pharmacy Board Regulations 3. Commercial Bribery/Kickback Statutes 4. State Insurance Regulation 5. False Claims Act (some states)

CONCLUSION PBMs today are where health insurors were in 1992 Rapidly escalating costs passed through to customers Increases in utilization of services result in increases in revenue No incentives to detect,control cost increases, fraud losses

FRAUD CONTROL MEASURES FOR PBMS Access to data,audit reports, software programs Requirements of Fraud Control-audits, attempt detection, referral for prosecutions, education, regular reporting of internal irregularities Effective internal and external compliance program

FRAUD CONTROL MEASURES FOR PBMs Respecting legal, professional duties and commitments of pharmacists Honoring responsibilities to patients-don t treat them like the cable company treats its customers Capturing, reporting errors, false records, misconduct within mail order pharmacies Capturing, responding to patient, physician complaints and concerns

TEN COMPLIANCE ISSUES FOR PBMS 1. ADOPT TRANSPARENCY STANDARDS USED BY EXPRESS SCRIPTS? 2. EXAMINE INVOICES FROM RETAIL PHARMACIES FOR GENERICS AND COMPARE THEM WITH INVOICES TO CUSTOMERS

TEN PBM QUESTIONS 3. ADMINISTRATIVE FEES FROM ANY DRUG MANUFACTURERS? WHICH ONES?HOW MUCH? WHAT FOR? 4. YOU HAVE NOMINAL PRICE AGREEMENTS FOR ANY DRUGS? WHICH ONES? HOW DISCLOSE TO PLANS/PATIENTS?

TEN PBM QUESTIONS 5. IS THE AVERAGE WHOLESALE PRICE YOU USE TO CALCULATE THE PRICE TO CLIENTS THE SAME AVERAGE WHOLESALE PRICE YOU USE TO CALCULATE PAYMENTS TO PHARMACIES? 6. WHAT OTHER PAYMENTS DO YOU GET FROM DRUG MANUFACTURERS BESIDES REBATES? WHAT DO YOU DO FOR EACH PAYMENT?

TEN PBM QUESTIONS 7. HOW DO YOU POLICE YOUR PHARMACY NETWORK- Audits Attempts DEA numbers Pay and chase?law enforcement referrals? 8. Do you report fraud to clients?

TEN QUESTIONS FOR PBMS 9. ARE YOUR REBATE CALCULATIONS ACCURATE? 10. DO YOU PAY HMOs, TPAs, or AGENTS to OBTAIN PBM CONTRACTS?HOW MUCH? WHAT FOR?